A novel therapeutic approach that combines human epidermal growth receptor factor 2 (HER2)-targeted therapies with the cholesterol-lowering drug lovastatin can reduce the number of cancer treatments required to prevent tumor ...
Oct 12, 2023
0
38
Acute myeloid leukemia (AML), the second most common leukemia in children, is hard to treat and has a five-year survival rate of just 65 to 70%, according to the American Cancer Society. While immunotherapies like monoclonal ...
Sep 30, 2023
0
21
There has been an outbreak of the deadly Nipah virus in Kerala, India. Five people have caught the virus, two of whom have died.
Sep 20, 2023
0
2
Some HIV-1 carriers who have received an early antiretroviral treatment during several years are able to control the virus for a long term after treatment interruption. However, the mechanisms enabling this post-treatment ...
Aug 8, 2023
0
64
With a new flu season upon us, scientists have been testing new ways of fighting the deadly disease with antibody-based therapies—and they've discovered that this approach may be effective in combating influenza B.
Aug 4, 2023
0
21
New therapies for early Alzheimer's disease, monoclonal antibodies that remove amyloid-β plaques in the brain, are bringing hope to people whose lives have been affected by the disease. To help neurologists discuss these ...
Jul 27, 2023
0
1
Research led by the Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, has found a potentially better alternative to standard antiretroviral treatment for controlling HIV-1 ...
Therapeutic antibodies that cause aggressive tumors to become susceptible to treatment are being studied with the hope of one day changing the fate of patients who either relapse soon after cancer therapy or whose stubborn ...
More than 6 million Americans are living with Alzheimer's disease, a staggering number that's expected to double within the next 30 years.
May 25, 2023
0
4
Antibody treatments exist for many diseases, but require injections or IV infusions, which are painful, inconvenient and carry risks. Now, a team of researchers at the University of Connecticut has created a way to deliver ...
Apr 13, 2023
0
32
